-
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy
Korst, C. L. B. M., Tahri, S., Duetz, C., Bruins, W. S. C., de Jonge, A. V., de Jong, M. E., Fokkema, C., Smits, F., Groen, K., Verkleij, C. P. M., Frerichs, K. A., Papazian, N., van Duin, M., van Beek, G., Hoogenboezem, R., Baardemans, T., Dal Collo, G., Stoetman, E. C. G., Cosovic, M. & Twickler, I. & 15 others, , 19 Jun 2025, In: Blood. 145, 25, p. 3007-3014 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Smits, F., Groen, K., Levin, M.-D., Stege, C., van Kampen, R. J. W., van der Spek, E., Bilgin, Y. M., Thielen, N., Nijhof, I. S., Ludwig, I., de Waal, E. G. M., Sandberg, Y., Kentos, A., Timmers, G.-J., Regelink, J. C., Westerman, M., Heer, K. D., Vekemans, M.-C. M., Durdu-Rayman, N. & de Graauw, N. C. H. P. & 5 others, , 22 Nov 2024, (E-pub ahead of print) In: Blood.Research output: Contribution to journal › Article* › Academic › peer-review
-
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes
Groen, K., Smits, F., Nasserinejad, K., Levin, M.-D., Regelink, J. C., Timmers, G.-J., de Waal, E. G. M., Westerman, M., Velders, G. A., de Heer, K., Leys, R. B. L., van Kampen, R. J. W., Stege, C. A. M., Seefat, M. R., Nijhof, I. S., van der Spek, E., Klein, S. K., van de Donk, N. W. C. J., Ypma, P. F. & Zweegman, S., 1 Jul 2024, In: HemaSphere. 8, 7, e85.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
